학술논문

Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
Document Type
Article
Source
In Blood Advances 27 September 2022 6(18):5285-5294
Subject
Language
ISSN
2473-9529